California-based medtech E2 has raised $80 million in a series C funding round as it looks to commercialize its pulmonary embolism treatment.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
California-based medtech E2 has raised $80 million in a series C funding round as it looks to commercialize its pulmonary embolism treatment.